Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

Prognostic Relevance of Steroid Sulfation in Adrenocortical Carcinoma Revealed by Molecular Phenotyping Using High-Resolution Mass Spectrometry Imaging.

Sun N, Kunzke T, Sbiera S, Kircher S, Feuchtinger A, Aichler M, Herterich S, Ronchi CL, Weigand I, Schlegel N, Waldmann J, Fragoso MCV, Whitsett TG, Gill AJ, Fassnacht M, Walch A, Kroiss M.

Clin Chem. 2019 Sep 6. pii: clinchem.2019.306043. doi: 10.1373/clinchem.2019.306043. [Epub ahead of print]

PMID:
31492715
2.

On the Ground of Nature: Sexuality and Respectability in Die Freundschaft's Wandervogel Stories.

Fassnacht M.

J Homosex. 2019 Sep 4:1-27. doi: 10.1080/00918369.2019.1656030. [Epub ahead of print]

PMID:
31483221
3.

Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma.

Siebert C, Ciato D, Murakami M, Frei-Stuber L, Perez-Rivas LG, Monteserin-Garcia JL, Nölting S, Maurer J, Feuchtinger A, Walch AK, Haak HR, Bertherat J, Mannelli M, Fassnacht M, Korpershoek E, Reincke M, Stalla GK, Hantel C, Beuschlein F.

Front Endocrinol (Lausanne). 2019 Jul 19;10:487. doi: 10.3389/fendo.2019.00487. eCollection 2019.

4.

Eighteenth Conference on the Adrenal Cortex Munich, Germany June 25-27, 2018.

Schimmer BP, Beuschlein F, Fassnacht M, Reincke M, Rainey WE.

J Steroid Biochem Mol Biol. 2019 Aug 1;194:105444. doi: 10.1016/j.jsbmb.2019.105444. [Epub ahead of print] No abstract available.

PMID:
31377234
5.

Pheochromocytoma and paraganglioma: Clinical feature based disease probability in relation to catecholamine biochemistry and reason for disease suspicion.

Geroula A, Deutschbein T, Langton K, Masjkur JR, Pamporaki C, Peitzsch M, Fliedner S, Timmers HJ, Bornstein SR, Beuschlein F, Stell A, Januszewicz A, Prejbisz A, Fassnacht M, Lenders J, Eisenhofer G.

Eur J Endocrinol. 2019 Aug 1. pii: EJE-19-0159.R2. doi: 10.1530/EJE-19-0159. [Epub ahead of print]

PMID:
31370000
6.

Synergistic Highly Potent Targeted Drug Combinations in different Pheochromocytoma Models including Human Tumor Cultures.

Fankhauser M, Bechmann N, Lauseker M, Goncalves J, Favier J, Klink B, William D, Gieldon L, Maurer J, Spöttl G, Rank P, Knösel T, Orth M, Ziegler CG, Aristizabal Prada ET, Rubinstein G, Fassnacht M, Spitzweg C, Grossman AB, Pacak K, Beuschlein F, Bornstein SR, Eisenhofer G, Auernhammer CJ, Reincke M, Nölting S.

Endocrinology. 2019 Jul 19. pii: en.2019-00410. doi: 10.1210/en.2019-00410. [Epub ahead of print]

PMID:
31322702
7.

Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study.

Winzeler B, Cesana-Nigro N, Refardt J, Vogt DR, Imber C, Morin B, Popovic M, Steinmetz M, Sailer CO, Szinnai G, Chifu I, Fassnacht M, Christ-Crain M.

Lancet. 2019 Aug 17;394(10198):587-595. doi: 10.1016/S0140-6736(19)31255-3. Epub 2019 Jul 11.

PMID:
31303316
8.

Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma.

Assié G, Jouinot A, Fassnacht M, Libé R, Garinet S, Jacob L, Hamzaoui N, Neou M, Sakat J, de La Villéon B, Perlemoine K, Ragazzon B, Sibony M, Tissier F, Gaujoux S, Dousset B, Sbiera S, Ronchi CL, Kroiss M, Korpershoek E, De Krijger R, Waldmann J, Quinkler M, Haissaguerre M, Tabarin A, Chabre O, Luconi M, Mannelli M, Groussin L, Bertagna X, Baudin E, Amar L, Coste J, Beuschlein F, Bertherat J.

JAMA Oncol. 2019 Jul 11. doi: 10.1001/jamaoncol.2019.1558. [Epub ahead of print]

PMID:
31294750
9.

Driver mutations in USP8 wild type Cushing's disease.

Sbiera S, Perez-Rivas LG, Taranets L, Weigand I, Flitsch J, Graf E, Monoranu CM, Saeger W, Hagel C, Honegger J, Assie G, Hermus AR, Stalla GK, Herterich S, Ronchi CL, Deutschbein T, Reincke M, Strom TM, Popov N, Theodoropoulou M, Fassnacht M.

Neuro Oncol. 2019 Jun 19. pii: noz109. doi: 10.1093/neuonc/noz109. [Epub ahead of print]

PMID:
31222332
10.

The challenges of sodium measurements - indirect versus direct ion selective method.

Refardt J, Sailer COO, Chifu I, Winzeler B, Schnyder I, Fassnacht M, Fenske WK, Christ-Crain M.

Eur J Endocrinol. 2019 Jun 1. pii: EJE-19-0101.R1. doi: 10.1530/EJE-19-0101. [Epub ahead of print]

PMID:
31167167
11.

A method for the minimally invasive drug monitoring of mitotane by means of volumetric absorptive microsampling for a home-based therapeutic drug monitoring.

Friedl B, Kurlbaum M, Kroiss M, Fassnacht M, Scherf-Clavel O.

Anal Bioanal Chem. 2019 Jul;411(17):3951-3962. doi: 10.1007/s00216-019-01868-1. Epub 2019 May 16.

PMID:
31093700
12.

Impact of USP8 Gene Mutations on Protein Deregulation in Cushing Disease.

Weigand I, Knobloch L, Flitsch J, Saeger W, Monoranu CM, Höfner K, Herterich S, Rotermund R, Ronchi CL, Buchfelder M, Glatzel M, Hagel C, Fassnacht M, Deutschbein T, Sbiera S.

J Clin Endocrinol Metab. 2019 Jul 1;104(7):2535-2546. doi: 10.1210/jc.2018-02564.

PMID:
30844069
13.

Impact of 123 I-MIBG scintigraphy on clinical decision making in pheochromocytoma and paraganglioma.

Rao D, van Berkel A, Piscaer I, Young WF, Gruber L, Deutschbein T, Fassnacht M, Beuschlein F, Spyroglou A, Prejbisz A, Hanus K, Eisenhofer G, Manelli M, Canu L, Lenders JWM, Bancos I, Timmers HJLM.

J Clin Endocrinol Metab. 2019 Mar 1. pii: jc.2018-02355. doi: 10.1210/jc.2018-02355. [Epub ahead of print]

PMID:
30822354
14.

The Adrenal Gland: Central Relay in Health and Disease.

Reincke M, Beuschlein F, Bornstein S, Eisenhofer G, Fassnacht M, Reisch N, Williams TA.

Exp Clin Endocrinol Diabetes. 2019 Feb;127(2-03):81-83. doi: 10.1055/a-0752-4176. Epub 2019 Feb 27.

15.

Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study.

Hescot S, Curras-Freixes M, Deutschbein T, van Berkel A, Vezzosi D, Amar L, de la Fouchardière C, Valdes N, Riccardi F, Do Cao C, Bertherat J, Goichot B, Beuschlein F, Drui D, Canu L, Niccoli P, Laboureau S, Tabarin A, Leboulleux S, Calsina B, Libé R, Faggiano A, Schlumberger M, Borson-Chazot F, Mannelli M, Gimenez-Roqueplo AP, Caron P, Timmers HJLM, Fassnacht M, Robledo M, Borget I, Baudin E; European Network for the Study of Adrenal Tumors (ENS@T).

J Clin Endocrinol Metab. 2019 Jun 1;104(6):2367-2374. doi: 10.1210/jc.2018-01968.

PMID:
30715419
16.

Alterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing Syndrome.

Bathon K, Weigand I, Vanselow JT, Ronchi CL, Sbiera S, Schlosser A, Fassnacht M, Calebiro D.

Endocrinology. 2019 Feb 1;160(2):447-459. doi: 10.1210/en.2018-00775.

PMID:
30615103
17.

FGF-21 levels in polyuria-polydipsia syndrome.

Refardt J, Sailer CO, Winzeler B, Betz MJ, Chifu I, Schnyder I, Fassnacht M, Fenske W, Christ-Crain M.

Endocr Connect. 2018 Dec 1;7(12):1501-1506. doi: 10.1530/EC-18-0469.

18.

[Erratum to: Thyroid gland and the heart].

Dischinger U, Fassnacht M.

Internist (Berl). 2019 Feb;60(2):216. doi: 10.1007/s00108-018-0532-0. German. No abstract available.

PMID:
30539196
19.

Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma.

Schweitzer S, Kunz M, Kurlbaum M, Vey J, Kendl S, Deutschbein T, Hahner S, Fassnacht M, Dandekar T, Kroiss M.

Eur J Endocrinol. 2019 Feb 1;180(2):117-125. doi: 10.1530/EJE-18-0782.

PMID:
30481155
20.

Advanced Adrenocortical Carcinoma - What to do when First-Line Therapy Fails?

Megerle F, Kroiss M, Hahner S, Fassnacht M.

Exp Clin Endocrinol Diabetes. 2019 Feb;127(2-03):109-116. doi: 10.1055/a-0715-1946. Epub 2018 Nov 23. Review.

21.

Patterns of Lymph Node Recurrence in Adrenocortical Carcinoma: Possible Implications for Primary Surgical Treatment.

Reibetanz J, Rinn B, Kunz AS, Flemming S, Ronchi CL, Kroiss M, Deutschbein T, Pulzer A, Hahner S, Kocot A, Germer CT, Fassnacht M, Jurowich C.

Ann Surg Oncol. 2019 Feb;26(2):531-538. doi: 10.1245/s10434-018-6999-z. Epub 2018 Nov 15.

PMID:
30443830
22.

Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours Registry.

Kroiss M, Deutschbein T, Schlötelburg W, Ronchi CL, Hescot S, Körbl D, Megerle F, Beuschlein F, Neu B, Quinkler M, Baudin E, Hahner S, Heidemeier A, Fassnacht M.

Exp Clin Endocrinol Diabetes. 2018 Nov 14. doi: 10.1055/a-0747-5571. [Epub ahead of print]

PMID:
30428495
23.

Variations in cardiovascular risk factors in people with and without migration background in Germany - Results from the STAAB cohort study.

Morbach C, Gelbrich G, Tiffe T, Eichner F, Wagner M, Heuschmann PU, Störk S; STAAB consortium, Frantz S, Maack C, Ertl G, Fassnacht M, Wanner C, Leyh R, Volkmann J, Deckert J, Faller H, Jahns R.

Int J Cardiol. 2019 Jul 1;286:186-189. doi: 10.1016/j.ijcard.2018.10.098. Epub 2018 Oct 30.

PMID:
30420145
24.

CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma.

Canu L, Van Hemert JAW, Kerstens MN, Hartman RP, Khanna A, Kraljevic I, Kastelan D, Badiu C, Ambroziak U, Tabarin A, Haissaguerre M, Buitenwerf E, Visser A, Mannelli M, Arlt W, Chortis V, Bourdeau I, Gagnon N, Buchy M, Borson-Chazot F, Deutschbein T, Fassnacht M, Hubalewska-Dydejczyk A, Motyka M, Rzepka E, Casey RT, Challis BG, Quinkler M, Vroonen L, Spyroglou A, Beuschlein F, Lamas C, Young WF, Bancos I, Timmers HJLM.

J Clin Endocrinol Metab. 2019 Feb 1;104(2):312-318. doi: 10.1210/jc.2018-01532.

PMID:
30383267
25.

Missed clinical clues in patients with pheochromocytoma/paraganglioma discovered by imaging.

Rogowski-Lehmann N, Geroula A, Prejbisz A, Timmers HJLM, Megerle F, Robledo M, Fassnacht M, Fliedner S, Reincke M, Stell A, Januszewicz A, Lenders J, Eisenhofer G, Beuschlein F.

Endocr Connect. 2018 Sep 1. pii: /journals/ec/aop/ec-18-0318.xml. doi: 10.1530/EC-18-0318. [Epub ahead of print]

26.

Influence of hormonal functional status on survival in adrenocortical carcinoma: systematic review and meta-analysis.

Vanbrabant T, Fassnacht M, Assie G, Dekkers OM.

Eur J Endocrinol. 2018 Dec 1;179(6):429-436. doi: 10.1530/EJE-18-0450. Review.

PMID:
30325179
27.

Hsp90 inhibition in adrenocortical carcinoma: Limited drug synergism with mitotane.

Sbiera S, Kendl S, Weigand I, Sbiera I, Fassnacht M, Kroiss M.

Mol Cell Endocrinol. 2019 Jan 15;480:36-41. doi: 10.1016/j.mce.2018.10.009. Epub 2018 Oct 10.

PMID:
30315857
28.

European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors

Fassnacht M, Dekkers OM, Else T, Baudin E, Berruti A, de Krijger R, Haak HR, Mihai R, Assie G, Terzolo M.

Eur J Endocrinol. 2018 Oct 1;179(4):G1-G46. doi: 10.1530/EJE-18-0608.

PMID:
30299884
29.

Volumetric and texture analysis of pretherapeutic 18F-FDG PET can predict overall survival in medullary thyroid cancer patients treated with Vandetanib.

Werner RA, Bundschuh RA, Higuchi T, Javadi MS, Rowe SP, Zsótér N, Kroiss M, Fassnacht M, Buck AK, Kreissl MC, Lapa C.

Endocrine. 2019 Feb;63(2):293-300. doi: 10.1007/s12020-018-1749-3. Epub 2018 Sep 11.

30.

Correction to: Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives.

Altieri B, Muscogiuri G, Paschou SA, Vryonidou A, Della Casa S, Pontecorvi A, Fassnacht M, Ronchi CL, Newell-Price J.

Endocrine. 2018 Dec;62(3):517-518. doi: 10.1007/s12020-018-1728-8.

PMID:
30203121
31.

Impact of chronic hyponatremia on neurocognitive and neuromuscular function.

Refardt J, Kling B, Krausert K, Fassnacht M, von Felten S, Christ-Crain M, Fenske W.

Eur J Clin Invest. 2018 Nov;48(11):e13022. doi: 10.1111/eci.13022. Epub 2018 Sep 19.

PMID:
30153330
32.

Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication.

Lippert J, Appenzeller S, Liang R, Sbiera S, Kircher S, Altieri B, Nanda I, Weigand I, Gehrig A, Steinhauer S, Riemens RJM, Rosenwald A, Müller CR, Kroiss M, Rost S, Fassnacht M, Ronchi CL.

J Clin Endocrinol Metab. 2018 Dec 1;103(12):4511-4523. doi: 10.1210/jc.2018-01348.

PMID:
30113656
33.

Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites.

Eisenhofer G, Prejbisz A, Peitzsch M, Pamporaki C, Masjkur J, Rogowski-Lehmann N, Langton K, Tsourdi E, Pęczkowska M, Fliedner S, Deutschbein T, Megerle F, Timmers HJLM, Sinnott R, Beuschlein F, Fassnacht M, Januszewicz A, Lenders JWM.

Clin Chem. 2018 Nov;64(11):1646-1656. doi: 10.1373/clinchem.2018.291369. Epub 2018 Aug 10.

PMID:
30097498
34.

Enzyme autoinduction by mitotane supported by population pharmacokinetic modelling in a large cohort of adrenocortical carcinoma patients.

Arshad U, Taubert M, Kurlbaum M, Frechen S, Herterich S, Megerle F, Hamacher S, Fassnacht M, Fuhr U, Kroiss M.

Eur J Endocrinol. 2018 Oct 16;179(5):287-297. doi: 10.1530/EJE-18-0342.

PMID:
30087117
35.

Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives.

Altieri B, Muscogiuri G, Paschou SA, Vryonidou A, Della Casa S, Pontecorvi A, Fassnacht M, Ronchi CL, Newell-Price J.

Endocrine. 2018 Dec;62(3):506-516. doi: 10.1007/s12020-018-1696-z. Epub 2018 Aug 2. Review. Erratum in: Endocrine. 2018 Sep 10;:.

PMID:
30073456
36.

Radiation Exposure of Adrenal Vein Sampling - a German Multicenter Study.

Fuss CT, Treitl M, Rayes N, Podrabsky P, Fenske WK, Heinrich DA, Reincke M, Petersen TO, Fassnacht M, Quinkler M, Kickuth R, Hahner S.

Eur J Endocrinol. 2018 Aug 1. pii: EJE-18-0328. doi: 10.1530/EJE-18-0328. [Epub ahead of print]

PMID:
30068731
37.

A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus.

Fenske W, Refardt J, Chifu I, Schnyder I, Winzeler B, Drummond J, Ribeiro-Oliveira A Jr, Drescher T, Bilz S, Vogt DR, Malzahn U, Kroiss M, Christ E, Henzen C, Fischli S, Tönjes A, Mueller B, Schopohl J, Flitsch J, Brabant G, Fassnacht M, Christ-Crain M.

N Engl J Med. 2018 Aug 2;379(5):428-439. doi: 10.1056/NEJMoa1803760.

38.

European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors.

Fassnacht M, Dekkers O, Else T, Baudin E, Berruti A, de Krijger RR, Haak HR, Mihai R, Assie G, Terzolo M.

Eur J Endocrinol. 2018 Jul 24. pii: EJE-18-0608. doi: 10.1530/EJE-18-0608. [Epub ahead of print]

PMID:
30042120
39.

Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients.

Calsina B, Currás-Freixes M, Buffet A, Pons T, Contreras L, Letón R, Comino-Méndez I, Remacha L, Calatayud M, Obispo B, Martin A, Cohen R, Richter S, Balmaña J, Korpershoek E, Rapizzi E, Deutschbein T, Vroonen L, Favier J, de Krijger RR, Fassnacht M, Beuschlein F, Timmers HJ, Eisenhofer G, Mannelli M, Pacak K, Satrústegui J, Rodríguez-Antona C, Amar L, Cascón A, Dölker N, Gimenez-Roqueplo AP, Robledo M.

Genet Med. 2018 Dec;20(12):1652-1662. doi: 10.1038/s41436-018-0068-7. Epub 2018 Jul 16.

PMID:
30008476
40.

Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.

Osswald A, Deutschbein T, Berr CM, Plomer E, Mickisch A, Ritzel K, Schopohl J, Beuschlein F, Fassnacht M, Hahner S, Reincke M.

Eur J Endocrinol. 2018 Aug;179(2):109-116. doi: 10.1530/EJE-18-0212. Epub 2018 Jun 6.

PMID:
29875286
41.

[Thyroid gland and the heart : Pathophysiological background, diagnostic and therapeutic consequences].

Dischinger U, Fassnacht M.

Internist (Berl). 2018 Jul;59(7):668-673. doi: 10.1007/s00108-018-0441-2. Review. German. Erratum in: Internist (Berl). 2018 Dec 11;:.

PMID:
29796905
42.

Adrenomedullary function, obesity and permissive influences of catecholamines on body mass in patients with chromaffin cell tumours.

An Y, Reimann M, Masjkur J, Langton K, Peitzsch M, Deutschbein T, Fassnacht M, Rogowski-Lehmann N, Beuschlein F, Fliedner S, Stell A, Prejbisz A, Januszewicz A, Lenders J, Bornstein SR, Eisenhofer G.

Int J Obes (Lond). 2019 Feb;43(2):263-275. doi: 10.1038/s41366-018-0054-9. Epub 2018 Mar 3.

PMID:
29717268
43.

Mitotane Monotherapy in Patients With Advanced Adrenocortical Carcinoma.

Megerle F, Herrmann W, Schloetelburg W, Ronchi CL, Pulzer A, Quinkler M, Beuschlein F, Hahner S, Kroiss M, Fassnacht M; German ACC Study Group.

J Clin Endocrinol Metab. 2018 Apr 1;103(4):1686-1695. doi: 10.1210/jc.2017-02591.

PMID:
29452402
44.

Antwort.

Megerle F, Fassnacht M.

Dtsch Med Wochenschr. 2018 Feb;143(3):200. doi: 10.1055/s-0044-100145. Epub 2018 Feb 6. German. No abstract available.

PMID:
29409094
45.

High-Resolution Tissue Mass Spectrometry Imaging Reveals a Refined Functional Anatomy of the Human Adult Adrenal Gland.

Sun N, Wu Y, Nanba K, Sbiera S, Kircher S, Kunzke T, Aichler M, Berezowska S, Reibetanz J, Rainey WE, Fassnacht M, Walch A, Kroiss M.

Endocrinology. 2018 Mar 1;159(3):1511-1524. doi: 10.1210/en.2018-00064.

46.

Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.

Heinze B, Fuss CT, Mulatero P, Beuschlein F, Reincke M, Mustafa M, Schirbel A, Deutschbein T, Williams TA, Rhayem Y, Quinkler M, Rayes N, Monticone S, Wild V, Gomez-Sanchez CE, Reis AC, Petersenn S, Wester HJ, Kropf S, Fassnacht M, Lang K, Herrmann K, Buck AK, Bluemel C, Hahner S.

Hypertension. 2018 Feb;71(2):317-325. doi: 10.1161/HYPERTENSIONAHA.117.09975. Epub 2017 Dec 26.

47.

Release and Decay Kinetics of Copeptin vs AVP in Response to Osmotic Alterations in Healthy Volunteers.

Fenske WK, Schnyder I, Koch G, Walti C, Pfister M, Kopp P, Fassnacht M, Strauss K, Christ-Crain M.

J Clin Endocrinol Metab. 2018 Feb 1;103(2):505-513. doi: 10.1210/jc.2017-01891.

PMID:
29267966
48.

[Pheochromocytoma - Current Recommendations on Diagnostics, Therapy and Follow-up].

Megerle F, Fassnacht M.

Dtsch Med Wochenschr. 2017 Dec;142(24):1797-1800. doi: 10.1055/s-0043-112777. Epub 2017 Dec 5. German.

PMID:
29207422
49.

ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas.

Laufs V, Altieri B, Sbiera S, Kircher S, Steinhauer S, Beuschlein F, Quinkler M, Willenberg HS, Rosenwald A, Fassnacht M, Ronchi CL.

Eur J Endocrinol. 2018 Feb;178(2):181-188. doi: 10.1530/EJE-17-0788. Epub 2017 Nov 29.

PMID:
29187510
50.

Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors.

Henning JEK, Deutschbein T, Altieri B, Steinhauer S, Kircher S, Sbiera S, Wild V, Schlötelburg W, Kroiss M, Perotti P, Rosenwald A, Berruti A, Fassnacht M, Ronchi CL.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):4323-4332. doi: 10.1210/jc.2017-01624.

PMID:
29092062

Supplemental Content

Loading ...
Support Center